Todd Girolamo - Jul 31, 2024 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
Chief Legal Officer
Signature
/s/ Todd Girolamo
Stock symbol
PROK
Transactions as of
Jul 31, 2024
Transactions value $
$0
Form type
4
Date filed
8/2/2024, 04:03 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PROK Class A Ordinary Shares Conversion of derivative security $0 +81.9K +100% $0.00 164K Jul 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Class B Ordinary Shares Conversion of derivative security $0 -81.9K -33.33% $0.00 164K Jul 31, 2024 Class A Ordinary Shares 81.9K $0.00 Direct F1, F2
transaction PROK Common Units in ProKidney LP Conversion of derivative security $0 -81.9K -33.33% $0.00 164K Jul 31, 2024 Class A Ordinary Shares 81.9K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis.
F2 The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire.
F3 The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.